C4 Therapeutics, Inc.(CCCC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CCCC C4 Therapeutics, Inc.

交易中 03-27 12:54:15 EDT

2.47

-0.15

-5.67%

最高2.60	最低2.47	成交量92.80万
今开2.60	昨收2.62	日振幅4.96%
总市值2.41亿	流通市值1.78亿	总股本9,758万
成交额234.04万	换手率1.29%	流通股本7,205万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CCCC","market":"US","secType":"STK","nameCN":"C4 Therapeutics, Inc.","latestPrice":2.4714,"timestamp":1774630441512,"preClose":2.62,"halted":0,"volume":927988,"delay":0,"changeRate":-0.05671755725190842,"floatShares":72053500,"shares":97578175,"eps":-1.266598,"marketStatus":"交易中","change":-0.1486,"latestTime":"03-27 12:54:15 EDT","open":2.6,"high":2.6,"low":2.47,"amount":2340414.1324328,"amplitude":0.049618,"askPrice":2.48,"askSize":1386,"bidPrice":2.47,"bidSize":2184,"shortable":3,"etf":0,"ttmEps":-1.266598,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774641600000},"marketStatusCode":2,"adr":0,"listingDate":1601611200000,"exchange":"NASDAQ","adjPreClose":2.62,"preHourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.62,"latestTime":"09:28 EDT","volume":1563,"amount":4110.6402966,"timestamp":1774618099025,"change":-0.02,"changeRate":-0.007634,"amplitude":0.015267},"postHourTrading":{"tag":"盘后","latestPrice":2.6382,"preClose":2.62,"latestTime":"19:11 EDT","volume":8086,"amount":21326.6415,"timestamp":1774566705940,"change":0.0182,"changeRate":0.006947,"amplitude":0.006947},"volumeRatio":0.830409,"impliedVol":1.3065,"impliedVolPercentile":0.5936},"requestUrl":"/m/hq/s/CCCC/tweets","defaultTab":"tweets","newsList":[{"id":"1158023539","title":"C4 Therapeutics启动Cemsidomide联合Elranatamab治疗复发/难治性多发性骨髓瘤的1B期临床试验首位患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1158023539","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158023539?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:02","pubTimestamp":1774436533,"startTime":"0","endTime":"0","summary":"C4 Therapeutics, Inc.宣布，其针对复发/难治性多发性骨髓瘤的1B期临床试验已完成首位患者给药。该试验旨在评估Cemsidomide与Elranatamab（商品名：Elrexfio®）联合疗法的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"gpt_icon":0},{"id":"1152815912","title":"C4 Therapeutics启动Cemsidomide联合地塞米松治疗复发/难治性多发性骨髓瘤的II期Momentum试验首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1152815912","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152815912?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:01","pubTimestamp":1771848077,"startTime":"0","endTime":"0","summary":"C4 Therapeutics公司宣布，其口服IKZF1/3降解剂Cemsidomide联合地塞米松治疗复发/难治性多发性骨髓瘤的II期Momentum临床试验已完成首例患者给药。这一进展标志着该创新疗法在临床开发中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"gpt_icon":0},{"id":"1177745828","title":"C4 Therapeutics第三季度每股收益为-0.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177745828","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177745828?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:56","pubTimestamp":1763571373,"startTime":"0","endTime":"0","summary":"11月6日 - C4 Therapeutics第三季度营收为1120万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","BK4139"],"gpt_icon":0},{"id":"2582392495","title":"C4 Therapeutics, Inc.盘中异动 下午盘急速上涨5.13%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582392495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582392495?lang=zh_cn&edition=full","pubTime":"2025-11-12 04:09","pubTimestamp":1762891751,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日04时09分，C4 Therapeutics, Inc.股票出现波动，股价快速拉升5.13%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家临床阶段的生物制药公司，致力于实现靶向蛋白质降解科学的承诺，创造新一代药物，改变患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111204091194fe3ffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111204091194fe3ffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","CCCC","BK4139","BK4007"],"gpt_icon":0},{"id":"1138004608","title":"C4 Therapeutics预计现有现金、现金等价物及可售证券将支持公司运营计划至2028年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1138004608","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138004608?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:22","pubTimestamp":1762431771,"startTime":"0","endTime":"0","summary":"C4 Therapeutics预计现有的现金、现金等价物及可售证券将使公司能够继续执行其运营计划，直至2028年底。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"gpt_icon":0},{"id":"1152011940","title":"C4 Therapeutics 第三季度每股收益为 -0.44 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152011940","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152011940?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:17","pubTimestamp":1762431463,"startTime":"0","endTime":"0","summary":"11月6日 - C4 Therapeutics 第三季度的收入为 1120 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"gpt_icon":0},{"id":"2518276177","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.08%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276177?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615807,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分，C4 Therapeutics, Inc.股票出现波动，股价大幅下挫5.08%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3220.76%、698.32%、113.46%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、32.14%、30.70%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221007abf30ae2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221007abf30ae2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CCCC","LENZ"],"gpt_icon":0},{"id":"2517943743","title":"C4 Therapeutics, Inc.2024财年实现净利润-1.05亿美元，同比增加20.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943743?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363236,"startTime":"0","endTime":"0","summary":"3月8日，C4 Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.05亿美元，同比增加20.45%；其中营业收入为35.58百万美元，同比增加71.39%，每股基本收益为-1.52美元。从资产负债表来看，C4 Therapeutics, Inc.总负债1.34亿美元，其中短期债务5.77百万美元，资产负债比为2.62，流动比率为0.06。机构评级：截至2025年3月8日，当前有8家机构对C4 Therapeutics, Inc.目标价做出预测，其中目标均价为15.56美元，其中最低目标价为3.00美元，最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000047abed65e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000047abed65e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","LENZ"],"gpt_icon":0},{"id":"2516634998","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.08%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634998?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012296,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，C4 Therapeutics, Inc.股票出现异动，股价快速跳水5.08%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Aeon Biopharma, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为46.98%、22.45%、21.63%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Akari Therapeutics Plc、Aim Immunotech Inc.，振幅分别为9.35%、6.78%、6.67%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231369637abd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231369637abd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","BK4139","LENZ"],"gpt_icon":0},{"id":"2514238389","title":"C4 Therapeutics, Inc.盘中异动 早盘股价大涨5.28%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514238389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:12","pubTimestamp":1740669153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时12分，C4 Therapeutics, Inc.股票出现波动，股价大幅拉升5.28%。截至发稿，该股报2.79美元/股，成交量8.1413万股，换手率0.12%，振幅6.79%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272312339632ba59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272312339632ba59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"gpt_icon":0},{"id":"2514886236","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.02%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514886236?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:16","pubTimestamp":1740600964,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时16分，C4 Therapeutics, Inc.股票出现异动，股价快速跳水5.02%。截至发稿，该股报2.65美元/股，成交量51.8944万股，换手率0.74%，振幅6.28%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041604abde381e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041604abde381e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"gpt_icon":0},{"id":"2514168440","title":"C4 Therapeutics, Inc.盘中异动 早盘大幅跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514168440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514168440?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:19","pubTimestamp":1740496795,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时19分，C4 Therapeutics, Inc.股票出现异动，股价大幅下挫5.19%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231955abdc8a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231955abdc8a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"gpt_icon":0},{"id":"2512993721","title":"C4 Therapeutics, Inc.盘中异动 下午盘急速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512993721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512993721?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:14","pubTimestamp":1739906065,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时14分，C4 Therapeutics, Inc.股票出现异动，股价急速下跌5.03%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为839.93%、208.49%、168.22%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031425a24ae70f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031425a24ae70f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","BK4139","LENZ"],"gpt_icon":0},{"id":"2510860361","title":"C4 Therapeutics, Inc.盘中异动 急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510860361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510860361?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:04","pubTimestamp":1739207046,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时04分，C4 Therapeutics, Inc.股票出现波动，股价急速跳水5.21%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010406a240c1f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010406a240c1f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","LENZ","BK4139"],"gpt_icon":0},{"id":"2509337602","title":"C4 Therapeutics, Inc.盘中异动 快速上涨5.00%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509337602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509337602?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:58","pubTimestamp":1738771100,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时58分，C4 Therapeutics, Inc.股票出现异动，股价快速上涨5.00%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4196.01%、1381.89%、1268.84%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为94.64%、59.80%、54.05%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235820987b8bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235820987b8bce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"gpt_icon":0},{"id":"2508734141","title":"C4 Therapeutics, Inc.盘中异动 早盘大幅下挫5.76%报3.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508734141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508734141?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593239,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，C4 Therapeutics, Inc.股票出现异动，股价急速跳水5.76%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为345.21%、277.89%、132.59%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、26.50%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322335998796f6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322335998796f6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"gpt_icon":0},{"id":"2507467088","title":"C4 Therapeutics, Inc.盘中异动 快速拉升5.01%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507467088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507467088?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:08","pubTimestamp":1738267719,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时08分，C4 Therapeutics, Inc.股票出现异动，股价急速拉升5.01%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040839abbd85e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040839abbd85e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"gpt_icon":0},{"id":"2503706647","title":"C4 Therapeutics, Inc.盘中异动 急速拉升6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503706647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503706647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951549,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，C4 Therapeutics, Inc.股票出现波动，股价急速上涨6.95%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、54.43%、35.46%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522323098673b6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522323098673b6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","BK4139","LENZ"],"gpt_icon":0},{"id":"2503571248","title":"C4 Therapeutics, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503571248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503571248?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:33","pubTimestamp":1736865182,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时33分，C4 Therapeutics, Inc.股票出现波动，股价大幅上涨5.14%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223302a221b8cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223302a221b8cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","LENZ","BK4139"],"gpt_icon":1},{"id":"2503583134","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.05%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503583134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503583134?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778712,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，C4 Therapeutics, Inc.股票出现波动，股价快速下挫5.05%。截至发稿，该股报3.48美元/股，成交量1.6627万股，换手率0.02%，振幅0.41%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223153aba93095&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223153aba93095&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.c4therapeutics.com","stockEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":0.0962},{"period":"3month","weight":0.2358},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.4162},{"period":"ytd","weight":0.3717}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0615},{"period":"3month","weight":-0.0655},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1345},{"period":"ytd","weight":-0.054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"C4 Therapeutics, Inc.于2015年10月7日在特拉华州注册成立。该公司是一家生物制药公司，致力于利用人体对蛋白质水平的自然调节作用，开发新的治疗性候选药物，以靶向和破坏引起疾病的蛋白质来治疗癌症，神经退行性疾病和其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.036957},{"month":2,"riseRate":0.5,"avgChangeRate":0.126939},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.192649},{"month":4,"riseRate":0.2,"avgChangeRate":-0.198802},{"month":5,"riseRate":0.4,"avgChangeRate":-0.071636},{"month":6,"riseRate":0.6,"avgChangeRate":-0.011627},{"month":7,"riseRate":1,"avgChangeRate":0.343381},{"month":8,"riseRate":0.4,"avgChangeRate":-0.01341},{"month":9,"riseRate":0.2,"avgChangeRate":-0.123891},{"month":10,"riseRate":0.4,"avgChangeRate":0.000588},{"month":11,"riseRate":0.5,"avgChangeRate":0.01571},{"month":12,"riseRate":0.166667,"avgChangeRate":0.247814}],"exchange":"NASDAQ","name":"C4 Therapeutics, Inc.","nameEN":"C4 Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"C4 Therapeutics, Inc.(CCCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供C4 Therapeutics, Inc.(CCCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"C4 Therapeutics, Inc.,CCCC,C4 Therapeutics, Inc.股票,C4 Therapeutics, Inc.股票老虎,C4 Therapeutics, Inc.股票老虎国际,C4 Therapeutics, Inc.行情,C4 Therapeutics, Inc.股票行情,C4 Therapeutics, Inc.股价,C4 Therapeutics, Inc.股市,C4 Therapeutics, Inc.股票价格,C4 Therapeutics, Inc.股票交易,C4 Therapeutics, Inc.股票购买,C4 Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"C4 Therapeutics, Inc.(CCCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供C4 Therapeutics, Inc.(CCCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}